Home / Market News / $CERT

$CERT news and market catalysts

The 13 most recent market catalysts affecting $CERT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

13 catalysts 3 high impact 6 bullish 6 bearish Healthcare Technology
Nov 6, 2026 Corporate Catalyst Bearish Impact 65
UBS Downgrades Certara to Neutral
UBS downgraded Certara's stock rating from Buy to Neutral, establishing a $13 price target. This decision directly follows Certara's recent third-quarter earnings report and update…
Nov 5, 2026 Corporate Catalyst Bearish Impact 75
Certara Reports Third Quarter 2026 Financial Results
Certara, Inc. reported its third-quarter 2026 financial results, showing a 4% increase in total revenue to $94.9 million. This growth was primarily fueled by an 11% rise in softwar…
Oct 27, 2026 Corporate Catalyst Bullish Impact 55
Certara Identified as Leader in AI-Powered Predictive Toxicology Market
This 8-K filing discloses that Certara, Inc. was the market leader in the global AI-powered predictive toxicology market in 2025 with a 4% share. This is a positive development for…
Oct 16, 2026 Corporate Catalyst Bullish Impact 55
Keybanc Maintains Overweight on Certara, Raises Price Target to $12
Keybanc analyst Scott Schoenhaus has maintained an 'Overweight' rating on Certara and raised the price target from $9 to $12. This action signals continued confidence in Certara's …
Oct 13, 2026 Corporate Catalyst Bullish Impact 55
TD Cowen Maintains Buy on Certara, Raises Price Target to $11
TD Cowen analyst Brendan Smith maintained a 'Buy' rating on Certara and raised the price target from $9 to $11. This action signals increased confidence from a prominent analyst re…
Oct 7, 2026 Corporate Catalyst Bullish Impact 55
Barclays Maintains Equal-Weight on Certara, Raises Price Target to $9
Barclays analyst Luke Sergott maintained an 'Equal-Weight' rating on Certara but raised the price target from $7.50 to $9. This action signals a slightly more optimistic view on Ce…
Sep 30, 2026 Corporate Catalyst Bearish Impact 55
UBS Downgrades Certara to Neutral, Maintains Price Target to $10
UBS analyst Kevin Caliendo downgraded Certara (CERT) from a 'Buy' to a 'Neutral' rating. This change in rating, while maintaining the $10 price target, suggests that UBS no longer …
Aug 5, 2026 Corporate Catalyst Bullish Impact 55
Barclays Maintains Equal-Weight on Certara, Raises Price Target to $7.5
This filing indicates that Barclays analyst Luke Sergott has raised his price target for Certara (CERT) from $6.5 to $7.5, while maintaining an 'Equal-Weight' rating. This is a mod…
Aug 4, 2026 Corporate Catalyst Neutral Impact 75
Transcript: Certara Q2 2026 Earnings Conference Call
Certara's Q2 2026 earnings call transcript reveals modest 1% revenue growth, with software up 4% and services down 3%. While the overall growth is low, the company is undertaking s…
Aug 4, 2026 Corporate Catalyst Bearish Impact 85
Certara shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY26 guidance below estimates.
This headline represents a significant corporate catalyst for Certara (CERT), directly impacting its stock price negatively due to fundamental underperformance. The 'worse-than-exp…
Aug 4, 2026 Corporate Catalyst Bearish Impact 85
Certara Lowers FY2026 Adj EPS Guidance from $0.35-$0.41 to $0.31-$0.36 vs $0.38 Est; Lowers FY2026 Sales Guidance from $395.000M-$405.000M to $367.000M-$382.000M vs $398.585M Est
Certara's decision to lower its FY2026 adjusted EPS and sales guidance is a significant negative development. The revised figures fall below current analyst estimates, suggesting t…
Aug 4, 2026 Corporate Catalyst Bearish Impact 92
Certara Q2 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $93.271M Miss $98.392M Estimate
Certara's Q2 earnings report revealed a miss on both adjusted EPS and revenue estimates. The company reported adjusted EPS of $0.08, falling short of the $0.09 consensus, and sales…
Jul 14, 2026 Corporate Catalyst Bullish Impact 55
HC Wainwright & Co. Maintains Buy on Cerrado Gold, Raises Price Target to C$3.4
HC Wainwright & Co. analyst Heiko F. Ihle maintained a 'Buy' rating on Cerrado Gold and slightly raised the price target from C$3.3 to C$3.4. This action signals continued confiden…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.